Format

Send to

Choose Destination
Lancet. 1994 Sep 17;344(8925):791-2.

Risks of immunodeficiency, AIDS, and death related to purity of factor VIII concentrate. Multicenter Hemophilia Cohort Study.

Author information

1
AIDS and Cancer Section, Viral Epidemiology Branch, National Cancer Institute, Rockville, Maryland.

Erratum in

  • Lancet 1994 Oct 29;344(8931):1238.

Abstract

In HIV-infected subjects with haemophilia, CD4 counts seem to fall more slowly in those on high-purity factor VIII (FVIII) than on intermediate-purity product. We evaluated whether risks for AIDS or death were associated with either product among 411 HIV-infected individuals. The relative hazard of AIDS was slightly elevated for both current (1.34) [corrected] and cumulative (1.01 per month) use of high-purity products (neither significant). The corresponding hazards for death were 1.49 and 1.03 (neither significant). Thus we found no evidence that high-purity FVIII concentrates retard the development of AIDS.

PMID:
7916077
DOI:
10.1016/s0140-6736(94)92345-0
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Elsevier Science
Loading ...
Support Center